Stem Cells—Yale Stem Cell Center
FDA Approves Second Round of Human Embryonic Stem Cell Trial
Using a patients own stem cells to replace diseased or damaged tissues might expose the patient to a risk of cancer according to the result of new research at Hebrew University of Jerusalem.
The Discovery raises a cautionary red flag in the advancing field of stem cell therapy. For years, embryonic stem cells were the focus of this field because they are undifferentiated and therefore have the potential to develop into any cell type in an adult body.
More here from Israel 21c Newsletter
Related: ObamaCare Funding Stem Cell Research –Reuters AlertNet
